Document:

Exhibit 10.3

 

CONSULTING AGREEMENT

 

This Consulting Agreement (“Agreement”),
effective as of ________, 2021 (“Effective Date”) is entered into by and between Biosecurity Technology, Inc
(Formerly known as Axelerex Corp, a Nevada corporation) ((the “Company”)), and ____________ (Referred to as
“Consultant”), an __________ resident.

 

RECITALS

 

WHEREAS, Company
desires to engage the services of Consultant, on a nonexclusive basis, to act as a general business consultant, by assisting and
advising the Company on the development and enhancement of the Company’s business.

 

NOW THEREFORE, in consideration of
the promises and the mutual covenants and agreements set forth below, the legal sufficiency of which is acknowledged, the parties
covenant and agree as follows:

 

(a) 1. Term
of Consultancy. Company agrees to retain the Consultant to act in a consulting capacity to the Company, and the Consultant
agrees to provide services to the Company, during the term commencing on the Effective Date and ending on the 6-month anniversary
of the Effective Date (the “Term”, which shall include any extension of this Agreement). This Agreement shall be automatically
renewed at the end of the Initial Term for successive six month terms (each, a “Renewal Term”) unless either party
hereto gives written notice of its intention not to renew sixty days (60) before expiration of the Initial Term or a Renewal Term.
A written notice of intention not to renew only affects the impending term and has no effect on the current six month term. The
Initial Term and any Renewal Terms shall collectively be referred to as the “Term”.

 

2. Duties
of Consultant. Consultant agrees that it will generally provide the following specified consulting services through its officers
and employees during the term:

 

(a) Consult
and assist the Company in developing and implementing appropriate plans and means for presenting the Company and its business plans,
strategy and personnel to the financial community, establishing an image for the Company in the financial community, and creating
the foundation for subsequent financial public relations efforts;

 

(b) Introduce
the Company to the financial community;

 

(c) Consult
and advise the Company in developing its business and implementing various methods to enhance the business of the Company;

 

(d) Research
and identify potential of business partners;

 

    1

     

    

 

(e)  Research
and identify personnel for the Company at an executive level and Board of Directors level;

 

(f)  Research
and identify related industries and new technologies, hardware or software partners, or equipment;

 

(g)  Research
and identify entities in the Company’s industry for potential synergistic opportunities;

 

(h) Assist
the Company in securing equipment or commercial real estate leases or other equipment financing;

 

(i) Upon
the Company’s approval, conduct meetings, in person or by telephone, in furtherance of its duties hereunder in order to further
the Company’s plans, goals and activities;

 

(j) At
the Company’s request, review business plans, strategies, mission statements budgets, proposed transactions and other plans;
and,

 

(k) Otherwise
perform as the Company's nonexclusive general business consultant.

 

(l) Assist
the Company in identifying potential merger and acquisition targets. Execute preliminary due diligence on said companies and identify
and recommend the capital structure for potential merger and acquisition targets.

 

(m) At
the company’s request, review short-term and long-term business goals and assist Company in creating internal control processes
to ensure accountability across all goals.

 

(n) Act
as key relationship contacts for all shareholders of the Company, including those participating in private placement opportunities
or institutional fundraising.

 

(o) Assist
the Company with all SEC-related matters, all administrative matters including the execution of subscription agreements, 8k filings,
cap structure, budget controls, investor relations and public relations contacts, and general business items which come up on a
routine basis.

 

(p)  Act
as consultant to direct investment of common stock or any other form of investment as approved by The Company

 

    2

     

    

 

3. Allocation
of Time and Energies. The Consultant hereby promises to perform and discharge faithfully the responsibilities which may be
assigned to the Consultant from time to time by the officers and duly authorized representatives of the Company in connection with
the conduct of its activities set forth hereunder, so long as such activities are in compliance with applicable securities laws
and regulations. Consultant and staff shall diligently and thoroughly provide the consulting services required hereunder. Although
no specific hours-per-day requirement will be required, Consultant and the Company agree that Consultant will perform the duties
set forth herein above in a diligent and professional manner. The parties acknowledge and agree that a disproportionately large
amount of the effort to be expended and the costs to be incurred by the Consultant and the benefits to be received by the Company
are expected to occur within or shortly after the first two months of the effectiveness of this Agreement. It is explicitly understood
that Consultant's performance of its duties hereunder will in no way be measured by the price of the Company's common stock, nor
the trading volume of the Company's common stock. It is also understood that the Company is entering into this Agreement with Consultant
and not any individual member of Consultant, and, as such, Consultant will not be deemed to have breached this Agreement if any
member, officer or director of the Consultant leaves the firm or dies or becomes physically unable to perform any meaningful activities
during the term of the Agreement, provided the Consultant otherwise performs its obligations under this Agreement.

 

4. Remuneration.
As full and complete compensation for services described in this Agreement, the Company shall compensate Consultant as follows:

 

4.1 Warrants
For undertaking this engagement and for other good and valuable consideration, the Company shall issue to Consultant _____ (four
hundred thousand) warrants at a cashless exercise price of .25/share and a 7-year term.

 

 4.3 Form of Issuance. With
each transfer of shares of Common Stock to be issued pursuant to this Agreement (collectively, “Shares”), Company
shall cause to be issued a certificate representing the Common Stock and a written opinion of counsel for the Company stating that
said shares are validly issued, fully paid and non-assessable and that the issuance and eventual transfer of them to Consultant
has been duly authorized by the Company. Company warrants that all Shares issued to Consultant pursuant to this Agreement shall
have been validly issued, fully paid and non-assessable and that the issuance and any transfer of them to Consultant shall have
been duly authorized by the Company’s board of directors. 

 

    3

     

    

 

 4.4 Restricted
Securities; Piggyback Rights. Consultant acknowledges that the Shares will not have been registered under the Securities Act
of 1933, and accordingly are “restricted securities” within the meaning of Rule 144 of the Act. As such, the Shares
may not be resold or transferred unless the shares have been included in a registration statement filed by the Company with the
Securities and Exchange Commission permitting the resale thereunder, or the Company has received an opinion of counsel that such
resale or transfer is exempt from the registration requirements of that Act. The Company will take all action as may be required
as a condition to the availability of Rule 144, and the Company will upon request supply written confirmation that it is in compliance
with the reporting requirements of Rule 144. The Company agrees to use its best efforts to facilitate and expedite transfers of
the Shares pursuant to Rule 144, which efforts shall include, but not be limited to, timely notice to its transfer agent to expedite
such transfers. With a view to making available the benefits of certain rules and regulations of the SEC which may at any time
permit the sale of the Shares to the public without registration, the Company agrees to:

 

		(i)	make and keep public information available, as those terms are understood and defined in Rule 144
under the Securities Act of 1933 (the “Act”), as amended, at all times after the effective date on which the
Company becomes subject to the reporting requirements of the Act or the Securities Exchange Act of 1934 (the “1934 Act”);

 

		(ii)	file with the SEC in a timely manner all reports and other documents required of the Company under
the Act and the 1934 Act;

 

		(iii)	not take any action or file any document (whether or not permitted by 1934 Act or the rules thereunder)
to terminate or suspend such registration or to terminate or suspend its reporting and filing obligations under said Act.

 

		(iv)	furnish to the Consultant forthwith, upon request, a written statement by the Company as to its
compliance with the reporting requirements of said Rule 144, and of the Act and the 1934 Act, a copy of the most recent annual
or quarterly report of the Company, and such other reports and documents of the Company and other information in the possession
of or reasonably obtainable by the Company as the Consultant may reasonably request in availing itself of any rule or regulation
of the SEC allowing the Consultant to sell any such Shares without registration.

 

The Consultant shall
have the right to include all of the shares of Common Stock underlying the Warrants (also referred to as the “Registrable
Securities”) as part of any registration of securities filed by the Company (other than in connection with a transaction
contemplated by Rule 145(a) promulgated under the Act or pursuant to Form S-8) and must be notified in writing of such filing.
Consultant shall have five (5) business days to notify the Company in writing as to whether the Company is to include Consultant
or not include Consultant as part of the registration; provided, however, that if any registration pursuant to this
Section shall be underwritten, in whole or in part, the Company may require that the Registrable Securities requested for inclusion
pursuant to this Section be included in the underwriting on the same terms and conditions as the securities otherwise being sold
through the underwriters. If in the good faith judgment of the underwriter evidenced in writing of such offering only a limited
number of Registrable Securities should be included in such offering, or no such shares should be included, the Consultant, and
all other selling stockholders, shall be limited to registering such proportion of their respective shares as shall equal the proportion
that the number of shares of selling stockholders permitted to be registered by the underwriter in such offering bears to the total
number of all shares then held by all selling stockholders desiring to participate in such offering.

  

    4

     

    

 

8. Indemnification.
The Company warrants and represents that all oral communications, written documents or materials furnished to Consultant by the
Company with respect to financial affairs, operations, profitability and strategic planning of the Company are accurate and Consultant
may rely upon the accuracy thereof without independent investigation. The Company will protect, indemnify and hold harmless Consultant
against any claims or litigation including any damages, liability, cost and reasonable attorney's fees as incurred with respect
thereto resulting from Consultant's communication or dissemination of any said information, documents or materials excluding any
such claims or litigation resulting from Consultant's communication or dissemination of information not provided or authorized
by the Company.

 

9. Representations.
Consultant represents that it is not required to maintain any licenses and registrations under federal or any state regulations
necessary to perform the services set forth herein. Consultant acknowledges that, to the best of its knowledge, the performance
of the services set forth under this Agreement will not violate any rule or provision of any regulatory agency having jurisdiction
over Consultant. Consultant acknowledges that, to the best of its knowledge, Consultant and its officers and directors are not
the subject of any investigation, claim, decree or judgment involving any violation of the SEC or securities laws. Consultant further
acknowledges that it is not a securities Broker Dealer or a registered investment advisor. Company acknowledges that, to the best
of its knowledge, that it has not violated any rule or provision of any regulatory agency having jurisdiction over the Company.
Company acknowledges that, to the best of its knowledge, Company is not the subject of any investigation, claim, decree or judgment
involving any violation of the SEC or securities laws.

 

10. Legal
Representation. The Company acknowledges that it has been represented by independent legal counsel in the preparation of this
Agreement. Consultant represents that it has consulted with independent legal counsel and/or tax, financial and business advisors,
to the extent the Consultant deemed necessary.

 

11. Status
as Independent Contractor. Consultant's engagement pursuant to this Agreement shall be as independent contractor, and not as
an employee, officer or other agent of the Company. Neither party to this Agreement shall represent or hold itself out to be the
employer or employee of the other. Consultant further acknowledges the consideration provided hereinabove is a gross amount of
consideration and that the Company will not withhold from such consideration any amounts as to income taxes, social security payments
or any other payroll taxes. All such income taxes and other such payment shall be made or provided for by Consultant and the Company
shall have no responsibility or duties regarding such matters. Neither the Company nor the Consultant possesses the authority to
bind each other in any agreements without the express written consent of the entity to be bound.

 

    5

     

    

 

14. Notices.
All notices, requests, and other communications hereunder shall be deemed to be duly given if sent by U.S. mail, postage prepaid,
addressed to the other party at the address as set forth herein below:

  

To the Company:

 

Biosecurity Technology,
Inc

3821 S. 148th
Street

Omaha, NE
68130

Attn: Dan Lynn

 

To the Consultant: 

 

 

 

 

 

Either party may change
the address to which notices for it shall be addressed by providing notice of such change to the other party in the manner set
forth in this Section 14.

 

15. Choice
of Law, Jurisdiction and Venue. This Agreement shall be governed by, construed and enforced in accordance with the laws of
the State of Minnesota. The parties agree that Hennepin County, Minnesota will be the venue of any dispute and will have jurisdiction
over all parties.

 

16. Complete
Agreement. This Agreement contains the entire agreement of the parties relating to the subject matter of this Agreement. This
Agreement and its terms may not be changed orally but only by an agreement in writing signed by the party against whom enforcement
of any waiver, change, modification, extension or discharge is sought.

  

    6

     

    

  

IN WITNESS WHEREOF, the parties have executed
this Consulting Agreement as of the Effective Date.

 

“Company”  

 

Biosecurity Technology, Inc

  

	Date:	 	 

 

	By: 	 	 
	 	Dan Lynn - CEO	 

  

“Consultant” 

 

Date:    

 

	By: 	  	 

  

    7Exhibit 10.4

 

NEITHER THE ISSUANCE AND SALE OF THE
SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE,
SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE
FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. 

 

	Warrant Shares: [________]	Issue Date: February __, 2021

 

COMMON STOCK PURCHASE WARRANT

 

Axelerex Corp., a corporation
organized under the laws of the State of Nevada (the “Company”), hereby certifies that, for value received,
or its assigns [_________________] (the “Holder”), is entitled, subject to the terms and limitations on exercise
and conditions hereinafter set fifth below, to purchase from the Company at any time after the Issue Date until 5:00 p.m., E.S.T
on the seventh anniversary of the Issue Date (the “Termination Date”), up to [______] fully paid and nonassessable
shares of Common Stock at a per share purchase price of $0.25 (the “Exercise Price"). The number and character
of such shares of Common Stock and the Exercise Price are subject to adjustment as provided herein. The Company may reduce the
Exercise Price for some or all of the Warrants, temporarily or permanently, provided such reduction is made as to all outstanding
Warrants for all Holders of such Warrants.

 

As used herein the
following terms, unless the context otherwise requires, have the following respective meanings:

 

(a) The
term “Company” shall mean Axelerex Corp., a Nevada corporation, and any corporation which shall succeed or assume
the obligations of the Company hereunder.

 

(b) The
term “Common Stock” includes (i) the Company's Common Stock, $0.001 par value per share, as authorized as of
the date hereof, and (ii) any other securities into which or for which any of the securities described in (i) may be converted
or exchanged pursuant to a plan of recapitalization, reorganization, merger, sale of assets or otherwise.

 

(c) The
term “Fundamental Transaction” shall mean that (i) the Company or any of its Subsidiaries shall, directly or
indirectly, in one or more related transactions, (1) consolidate or merge with or into (whether or not the Company or any of its
Subsidiaries is the surviving corporation) any other Person, or (2) sell, lease, license, assign, transfer, convey or otherwise
dispose of all or substantially all of its respective properties or assets to any other Person, or (3) allow any other Person to
make a purchase, tender or exchange offer that is accepted by the holders of more than fifty percent (50%) of the outstanding shares
of the Company’s voting capital stock (“Voting Stock”), or (4) consummate a stock or share purchase agreement
or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement)
whereby more than fifty percent (50%)  of the outstanding shares of Voting Stock of the Company are issued, or (5)  reorganize,
recapitalize or reclassify the Common Stock, or (ii) any “person” or “group” (as these terms are used for
purposes of Sections 13(d) and 14(d) of the Exchange Act and the rules and regulations promulgated thereunder) is or shall become
the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of fifty percent
(50%)  of the aggregate ordinary voting power represented by issued and outstanding Voting Stock of the Company

 

    1

     

    

 

(d) The
term “Other Securities” refers to any stock (other than Common Stock) and other securities of the Company or
any other person (corporate or otherwise) which the holder of the Warrant at any time shall be entitled to receive, or shall have
received, on the exercise of the Warrant, in lieu of or in addition to Common Stock, or which at any time shall be issuable or
shall have been issued in exchange for or in replacement of Common Stock or Other Securities pursuant to Section 4 or otherwise.

 

(e)  The
term “Trading Day” means a day on which the principal Trading Market is open for trading.

 

(f) The
term “Trading Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted
for trading on the date inquisition; the Nasdaq Capital Market, the Nasdaq Global Market, the New York Stock Exchange, the NYSE
America, OTCQB, OTCQX, or OTC Markets (or any successor of the foregoing).

 

(g) The
term “Warrant Shares” shall mean the Common Stock issuable upon exercise of this Warrant.

 

1. Exercise
of Warrant.

 

1.1. Number
of Shares Issuable upon Exercise. From and after the Issue Date through and including the Termination Date, the Holder hereof
shall be entitled to receive, upon exercise of this Warrant in whole in accordance with the terms of subsection 1.2 or upon exercise
of this Warrant in part in accordance with subsection 1.3, shares of Common Stock of the Company, subject to adjustment pursuant
to Section 4.

 

1.2. Full
Exercise. This Warrant may be exercised in full by the Holder hereof by delivery of an original or facsimile copy of the form
of exercise notice attached as Exhibit A hereto (the “Notice of Exercise”) duly executed by such Holder and
delivery within two days thereafter of payment, provided the Warrant is not being exercised on a cashless basis as set forth herein,
in cash, wire transfer or by certified or official bank check payable to the order of the Company, in the amount obtained by multiplying
the number of shares of Common Stock for which this Warrant is then exercisable by the Exercise Price then in effect. The original
Warrant is not required to be surrendered to the Company until it has been fully exercised.

 

1.3. Partial
Exercise. This Warrant may be exercised in part (but not for a fractional share) by delivery of a Notice of Exercise in the
manner and at the place provided in the Notice of Exercise except that the amount payable by the Holder on such partial exercise
shall be the amount obtained by multiplying (a) the number of whole shares of Common Stock designated by the Holder in the
Notice of Exercise by (b) the Exercise Price then in effect. On any such partial exercise provided the Holder has surrendered
the original Warrant, the Company, at its expense, will forthwith issue and deliver to or upon the order of the Holder hereof a
new Warrant of like tenor, in the name of the Holder hereof or as such Holder (upon payment by such Holder of any applicable transfer
taxes) may request, the whole number of shares of Common Stock for which such Warrant may still be exercised.

 

    2

     

    

 

1.4. Company
Acknowledgment. The Company will, at the time of the exercise of the Warrant, upon the request of the Holder hereof, acknowledge
in writing its continuing obligation to afford to such Holder any rights to which such Holder shall continue to be entitled after
such exercise in accordance with the provisions of this Warrant. If the Holder shall fail to make any such request, such failure
shall not affect the continuing obligation of the Company to afford to such Holder any such rights.

 

1.5. Delivery
of Stock Certificates, etc. on Exercise. The Company agrees that, provided the full Exercise Price listed in the Notice of
Exercise is received as specified in Section 1.2 or Section 1.3, of the Warrants are exercised on a cashless basis pursuant to
Section 2, the shares of Common Stock purchased upon exercise of this Warrant shall be deemed to be issued to the Holder hereof
as the record owner of such shares as of the close of business on the date on which delivery of a Notice of Exercise shall have
occurred and payment (if applicable) made for such shares as aforesaid. As soon as practicable after the exercise of this Warrant,
in full or in part, and in any event within three (3) business days thereafter (“Warrant Share Delivery Date”),
the Company at its expense (including the payment by it of any applicable issue taxes) will cause to be issued in the name of and
delivered to the Holder hereof, or as such Holder (upon payment by such Holder of any applicable transfer taxes) may direct in
compliance with applicable securities laws, (1) provided that (x) the Transfer Agent is participating in DTC Fast Automated Securities
Transfer Program and (y) such Warrant Shares to be so issued are eligible for resale pursuant to Rule 144, such aggregate number
of Warrant Shares to which such Holder shall be entitled to such Holder’s or its designee’s balance account with DTC
through its Deposit/Withdrawal at Custodian system, or (2) if either of the immediately preceding clauses (x) or (y) are not satisfied,
a certificate or certificates for the number of duly and validly issued, fully paid and non-assessable shares of Common Stock (or
Other Securities) to which such Holder shall be entitled on such exercise, plus, in lieu of any fractional share to which such
Holder would otherwise be entitled, at the Company’s option an additional share of Common Stock by rounding up to the next
whole share or cash equal to such fraction multiplied by the then Fair Market Value of one full share of Common Stock, together
with any other stock or other securities and property (including cash, where applicable) to which such Holder is entitled upon
such exercise pursuant to Section 1 or otherwise. The Company understands that a delay in the delivery of the Warrant Shares
after the Warrant Share Delivery Date could result in economic loss to the Holder.

 

    3

     

    

 

2. Cashless
Exercise. Payment upon exercise of this Warrant may be made at the option of the Holder either in (i) cash, wire transfer
or by certified or official bank check payable to the order of the Company equal to the applicable aggregate Purchase Price, or,
in whole or in part, by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of
Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A)     = as applicable:
(i) either the last bid or trade price, at the sole option of the Holder, of the Common Stock on the Trading Market on the Trading
Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered
pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a)
hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b)(64) of Regulation
NMS promulgated under the federal securities laws) on such Trading Day, or (ii) the Bid Price of the Common Stock on the principal
Trading Market as reported by Bloomberg L.P. as of the time of the Holder’s execution of the applicable Notice of Exercise
if such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within two
(2) hours thereafter pursuant to Section 2(a) hereof or;

 

(B)     = the existing
Exercise Price of this Warrant at the time of such exercise; and

 

(X)      
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant
if such exercise were by means of a cash exercise rather than a cashless exercise.

 

For purposes of Rule 144 promulgated under
the 1933 Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction in
the manner described above shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall
be deemed to have commenced, on the date this Warrant was originally issued.

 

3. Adjustment
for Reorganization, Consolidation, Merger, etc.

 

3.1. Fundamental Transaction.
If, at any time while this Warrant is outstanding, (A) the Company effects any Fundamental Transaction then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon
such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder, upon exercise
of this Warrant, the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the
surviving corporation, and any additional consideration (the "Alternate Consideration") receivable upon or as a result of
such reorganization, reclassification, merger, consolidation or disposition of assets by a Holder of the number of shares of Common Stock
for which this Warrant is exercisable immediately prior to such event. For purposes of any such exercise, the determination of
the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise
Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the
Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received
in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon
any exercise of this Warrant following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions,
any successor to the Company or surviving entity in such Fundamental Transaction shall issue to the Holder a new warrant consistent
with the foregoing provisions and evidencing the Holder's right to exercise such warrant into Alternate Consideration.  The
terms of any agreement pursuant to which a Fundamental Transaction is effected shall include terms requiring any such successor
or surviving entity to comply with the provisions of this Section 3.1 and insuring that this Warrant (or
any such replacement security) will be similarly adjusted upon any subsequent transaction analogous to a Fundamental
Transaction.

 

    4

     

    

 

3.2. Continuation
of Terms. Upon any reorganization, consolidation, merger or transfer (and any dissolution following any transfer) referred
to in Section 3.1, this Warrant shall continue in full force and effect and the terms hereof shall be applicable to the Other Securities
and property receivable on the exercise of this Warrant after the consummation of such reorganization, consolidation or merger
or the effective date of dissolution following any such transfer, as the case may be, and shall be binding upon the issuer of any
Other Securities, including, in the case of any such transfer, the person acquiring all or substantially all of the properties
or assets of the Company, whether or not such person shall have expressly assumed the terms of this Warrant as provided in Section 3.1.

 

3.3 Share
Issuance. If, at any time while this Warrant is outstanding, the Company or any Subsidiary, as applicable, sells or grants
any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant
or any option to purchase or other disposition), any Common Stock or common stock equivalents entitling any Person to acquire shares
of Common Stock at or with a conversion formula that creates an effective price per share that is lower than the then Exercise
Price (such lower price or conversion formula, the “Base Exercise Price” and such issuances, collectively, a “Dilutive
Issuance”) (if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation
of exercise price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants,
options or rights per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at
an effective price per share that is lower than the Exercise Price, such issuance shall be deemed to have occurred for less than
the Exercise Price on such date of the Dilutive Issuance), then the Exercise Price shall be reduced to equal the Base Exercise
Price. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued. Notwithstanding the foregoing,
no adjustment will be made under this Section 3.3 in respect of an Exempt Issuance.

 

4. Extraordinary
Events Regarding Common Stock. In the event that the Company shall (a) issue additional shares of the Common Stock as
a dividend or other distribution on outstanding Common Stock, (b) subdivide its outstanding shares of Common Stock, or (c) combine
its outstanding shares of the Common Stock into a smaller number of shares of the Common Stock, then, in each such event, the Exercise
Price shall, simultaneously with the happening of such event, be adjusted by multiplying the then Exercise Price by a fraction,
the numerator of which shall be the number of shares of Common Stock outstanding immediately prior to such event and the denominator
of which shall be the number of shares of Common Stock outstanding immediately after such event, and the product so obtained shall
thereafter be the Exercise Price then in effect. The Exercise Price, as so adjusted, shall be readjusted in the same manner upon
the happening of any successive event or events described herein in this Section 4. The number of shares of Common Stock that
the Holder of this Warrant shall thereafter, on the exercise hereof, be entitled to receive shall be adjusted to a number determined
by multiplying the number of shares of Common Stock that would otherwise (but for the provisions of this Section 4) be issuable
on such exercise by a fraction of which (a) the numerator is the Exercise Price that would otherwise (but for the provisions of
this Section 4) be in effect, and (b) the denominator is the Exercise Price in effect on the date of such exercise.

 

    5

     

    

 

5. Certificate
as to Adjustments. In each case of any adjustment or readjustment in the shares of Common Stock (or Other Securities) issuable
on the exercise of the Warrants, the Company at its expense will promptly cause its Chief Financial Officer or other appropriate
designee to compute such adjustment or readjustment in accordance with the terms of the Warrant and prepare a certificate setting
forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based, including
a statement of (a) the consideration received or receivable by the Company for any additional shares of Common Stock (or Other
Securities) issued or sold or deemed to have been issued or sold, (b) the number of shares of Common Stock (or Other Securities)
outstanding or deemed to be outstanding, and (c) the Exercise Price and the number of shares of Common Stock to be received upon
exercise of this Warrant, in effect immediately prior to such adjustment or readjustment and as adjusted or readjusted as provided
in this Warrant. The Company will forthwith mail a copy of each such certificate to the Holder of the Warrant and any Warrant Agent
of the Company (appointed pursuant to Section 11 hereof).

 

6. Reservation
of Stock, etc. Issuable on Exercise of Warrant; Financial Statements. The Company will at all times reserve and keep available,
solely for issuance and delivery on the exercise of the Warrants, all shares of Common Stock (or Other Securities) from time to
time issuable on the exercise of the Warrant.

 

7. Assignment;
Exchange of Warrant. Subject to compliance with applicable securities laws, this Warrant, and the rights evidenced hereby,
may be transferred by any registered holder hereof (a "Transferor"). On the surrender for exchange of this Warrant,
with the Transferor's endorsement in the form of Exhibit B attached hereto (the “Transferor Endorsement Form")
and together with an opinion of counsel reasonably satisfactory to the Company that the transfer of this Warrant will be in compliance
with applicable securities laws, the Company will issue and deliver to or on the order of the Transferor thereof a new Warrant
or Warrants of like tenor, in the name of the Transferor and/or the transferee(s) specified in such Transferor Endorsement Form
(each a "Transferee"), calling in the aggregate on the face or faces thereof for the number of shares of Common
Stock called for on the face or faces of the Warrant so surrendered by the Transferor.

 

8. Replacement
of Warrant. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant and, in the case of any such loss, theft or destruction of this Warrant, on delivery of an indemnity agreement or
security reasonably satisfactory in form and amount to the Company or, in the case of any such mutilation, on surrender and cancellation
of this Warrant, the Company at its expense, twice only, will execute and deliver, in lieu thereof, a new Warrant of like tenor.

 

    6

     

    

 

9. Maximum
Exercise. The Holder shall not be entitled to exercise this Warrant on an exercise date, in connection with that number of
shares of Common Stock which would be in excess of the sum of (i) the number of shares of Common Stock beneficially owned
by the Holder and its affiliates on an exercise date, and (ii) the number of shares of Common Stock issuable upon the exercise
of this Warrant with respect to which the determination of this limitation is being made on an exercise date, which would result
in beneficial ownership by the Holder and its affiliates of more than 4.99% of the outstanding shares of Common Stock on such date.
For the purposes of the immediately preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d) of
the 1934 Act and Rule 13d-3 thereunder. Subject to the foregoing, the Holder shall not be limited to aggregate exercises which
would result in the issuance of more than 4.99%. The restriction described in this paragraph may be waived, in whole or in
part, upon sixty-one (61) days prior notice from the Holder to the Company to increase such percentage to up to 9.99%, but not
in excess of 9.99%.

 

10. Warrant
Agent. The Company may, by written notice to the Holder of the Warrant, appoint an agent (a “Warrant Agent”)
for the purpose of issuing Common Stock (or Other Securities) on the exercise of this Warrant pursuant to Section 1 and 2, transferring
this Warrant pursuant to Section 7, and replacing this Warrant pursuant to Section 8, or any of the foregoing, and thereafter any
such issuance, exchange or replacement, as the case may be, shall be made at such office by such Warrant Agent.

 

11. Transfer
on the Company's Books. Until this Warrant is transferred on the books of the Company, the Company may treat the registered
holder hereof as the absolute owner hereof for all purposes, notwithstanding any notice to the contrary.

 

12. Notices.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return
receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery, electronic mail, telegram, or facsimile, to such address as such party shall have specified most recently by
written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon
hand delivery, electronic mail, or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine,
at the address or number designated below (if delivered on a business day during normal business hours where such notice is to
be received), or the first business day following such delivery (if delivered other than on a business day during normal business
hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service,
fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur.

 

    7

     

    

 

13. Law
Governing This Warrant. This Warrant shall be governed by and construed in accordance with the laws of the State of Nevada
without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions
contemplated by this Warrant shall be brought only in the state courts of New York or in the federal courts located in the state
and county of New York. The parties to this Warrant hereby irrevocably waive any objection to jurisdiction and venue of any action
instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens.
The Company and Holder waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable
attorney's fees and costs. In the event that any provision of this Warrant or any other agreement delivered in connection herewith
is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the
extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision
which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of
any agreement. Each party hereby irrevocably waives personal service of process and consents to process being served in any suit,
action or proceeding in connection with this Agreement or any other Transaction Document by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under
this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

(Remainder of page left intentionally
blank.)

 

    8

     

    

 

IN WITNESS WHEREOF, the
Company has executed this Warrant as of the date first written above.

 

	 	AXELEREX CORP.
	 	 
	 	By:	      
	 	 	Name: Dan Lynn
	 	 	Title: Chief Executive Officer

 

    9

     

    

 

Exhibit A

 

FORM OF NOTICE OF EXERCISE

(to be signed only on exercise of Warrant)

 

To: Axelerex Corp.

[_________________]

[_________________]

 

(1) The undersigned hereby
elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full),
and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

  

(2) Payment shall take
the form of (check applicable box):

 

☐ in lawful
money of the United States; or

 

 ☐ [if
permitted] the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in
Section 2, to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless
exercise procedure set forth in Section 2. 

 

(3) Please issue said
Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

The Warrant Shares shall be delivered to
the following DWAC Account Number:

 

_______________________________

 

_______________________________

 

_______________________________

 

(4) Accredited
Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities
Act of 1933, as amended.

 

 

___________________________

[SIGNATURE
OF HOLDER]

 

    10

     

    

 

Exhibit B

 

FORM OF TRANSFEROR ENDORSEMENT

(To be signed only on transfer of Warrant)

 

For value received, the
undersigned hereby sells, assigns, and transfers unto the person(s) named below under the heading "Transferees" the right
represented by the within Warrant to purchase the percentage and number of shares of Common Stock of Axelerex Corp. to which the
within Warrant relates specified under the headings "Percentage Transferred" and "Number Transferred," respectively,
opposite the name(s) of such person(s) and appoints each such person Attorney to transfer its respective right on the books of
Axelerex Corp. with full power of substitution in the premises.

  

	Transferees	Percentage Transferred	Number Transferred
	 	 	 
	 	 	 
	 	 	 

  

	Dated:  ______________, 20____	 	 
	 	 	(Signature must conform to name of holder as specified on the face of the warrant)
	Signed in the presence of:	 	 
	 	 	
		 	
	      (Name)	 	      (address)
	 	 	 
	ACCEPTED AND AGREED:	 	
	[TRANSFEREE]	 	
	 	 	      (address)
		 	 
	      (Name)	 	 

  

    11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}]]